Analysis of tumor tissue obtained from intraperitoneal xenografts after a combined treatment with an anti-MMP9 antibody and NPT revealed a decrease in the levels of stromal and EMT markers, such as smooth muscle alpha-actin (αSMA or ACTA2), collagen I, and vimentin in comparison with NPT + GEM therapy alone. The gene discussed is MMP9; the disease is neoplasm.